Ductus Arteriosus Stent for Congenital Heart Disease

This trial explores a new stent designed to assist babies with certain congenital heart defects requiring specific blood flow through the heart. The Ductus Arteriosus Stent aims to keep the Ductus Arteriosus (a blood vessel in the heart) open, crucial for infants relying on this pathway for circulation. Babies under 6 months old with heart conditions needing medication for blood flow may qualify for this study. As an unphased trial, it offers families a unique opportunity to contribute to groundbreaking research that could enhance future treatments for congenital heart defects.

The trial does not specify if you need to stop taking your current medications, but it does require that participants need prostaglandin infusions. It's best to discuss your current medications with the trial team.

Research has shown that the Ductus Arteriosus Stent is generally well-tolerated. In one study, 93% of patients who received the stent had successful outcomes, with only one instance of the stent moving from its intended position. Another review found that patients with this stent experienced fewer complications compared to those who underwent traditional surgery. Additionally, the stent was associated with lower death rates and shorter hospital stays. These findings suggest that the stent offers a promising option for those needing this procedure, with fewer risks than surgery.¹²³⁴⁵

Unlike the standard treatment options for congenital heart disease, which typically involve surgical procedures or medications, the Ductus Arteriosus Stent offers a less invasive alternative. This stent is designed to keep the ductus arteriosus open, which is crucial for certain congenital heart conditions. Researchers are excited about this stent because it provides a targeted approach, potentially reducing the need for more invasive surgeries and improving outcomes for newborns with specific heart defects. Additionally, the stent's design aims to offer a longer-term solution compared to temporary measures, enhancing the quality of life for patients.

Research has shown that the Ductus Arteriosus Stent, which participants in this trial will receive, helps maintain blood flow in children with certain heart conditions. One study found that doctors successfully placed the stent 93% of the time, with only one reported death during the procedure. Stenting has improved oxygen levels in babies, with all cases in another study being successful. A review of several studies found that stenting results in fewer deaths and shorter hospital stays compared to other treatments. Overall, this stenting method is considered a safe and effective alternative to more invasive surgeries.²⁴⁵⁶⁷